Seeing Is Believing
Currently out of the existing stock ratings of Samuel Brodovsky, 25 are a BUY (69.44%), 11 are a HOLD (30.56%).
Analyst Samuel Brodovsky, currently employed at TRUIST, carries an average stock price target met ratio of 71.86% that have a potential upside of 21.88% achieved within 88 days.
Samuel Brodovsky’s has documented 72 price targets and ratings displayed on 4 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on SIBN, Si-Bone at 25-Feb-2025.
Analyst best performing recommendations are on VCEL (VERICEL CORP ORD).
The best stock recommendation documented was for VCEL (VERICEL CORP ORD) at 1/31/2023. The price target of $29 was fulfilled within 2 days with a profit of $1.53 (5.57%) receiving and performance score of 27.85.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$26
$7.51 (40.62%)
$42
1 months ago
(29-Oct-2025)
6/21 (28.57%)
$9.54 (57.96%)
172
Buy
$23
$4.51 (24.39%)
$23
1 months ago
(29-Oct-2025)
5/11 (45.45%)
$6.54 (39.73%)
106
Buy
$25
$6.51 (35.21%)
$50
1 months 19 days ago
(10-Oct-2025)
2/13 (15.38%)
$8.7 (53.37%)
58
Buy
$20
$1.51 (8.17%)
$32
1 months 19 days ago
(10-Oct-2025)
6/8 (75%)
$3.7 (22.70%)
89
Buy
$22
$3.51 (18.98%)
$30
1 months 19 days ago
(10-Oct-2025)
19/25 (76%)
$5.7 (34.97%)
102
What Year was the first public recommendation made by Samuel Brodovsky?